跳至主要内容
临床试验/CTRI/2019/04/018550
CTRI/2019/04/018550尚未招募未知

Silymarin-Choline Combination Versus Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver Disease: A Randomised Double-Blind Clinical Trial

Medical College Kolkata0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients of either sex from 18 years to 60 years 2. Patients diagnosed with Non Alcoholic Fatty Liver Disease attending Medicine OPD, Medical Gastroenterology OPD, Liver Clinic of Medical College and Hospital Kolkata

排除标准

  • 1. Ethanol intake > 20 g/ day
  • 2. History of ingestion of drugs known to produce fatty liver disease (such as steroids, estrogens, amiodarone, tamoxifen or other chemotherapeutic agents etc.)
  • 3. Diabetes
  • 4. Viral Hepatitis (HBV, HCV), HIV
  • 5. Severely ill requiring hospital indoor services or critical care
  • 6. Pregnancy

研究者

相似试验

Silymarin-Choline Combination Versus Ursodeoxycholic... | 临床试验